Rapid vaccination deployed during epidemic outbreaks has been found to reduce mortality from diseases such as cholera, Ebola, and measles by nearly 60 percent. This significant finding comes from researchers at the Burnet Institute, who conducted an analysis of 210 disease outbreaks across 49 low-income countries between 2000 and 2023. The detailed results of their study have been published in the journal BMJ Global Health.
The study highlighted a particularly strong effect for yellow fever and Ebola, where emergency vaccination led to a dramatic 99 percent and 76 percent decrease in deaths, respectively. Beyond saving lives, the introduction of these rapid vaccine programs also substantially limited the overall spread of epidemics and prevented millions of potential infections.
According to the authors` economic assessment, these timely vaccination efforts generated an estimated economic benefit of nearly $32 billion. This calculation was based primarily on the value of preventing deaths and long-term disabilities. The researchers note that the actual economic benefit is likely much higher, as their estimate did not include the substantial costs involved in managing large-scale epidemics or the wider negative impacts on national economies.
The authors strongly emphasize that widespread vaccination remains the most effective strategy for protecting global public health. They highlight its critical importance, especially in light of the increasing frequency of outbreaks of preventable diseases and potential challenges in maintaining levels of international aid.
